The Central Role Played by Peptides in the Immune Response and the Design of Peptide-Based Vaccines Against Infectious Diseases and Cancer
Journal:
Current Drug Targets
Volume:
3
Page:
175-196
Author(s):
D. C. Jackson, A. W. Purcell, C. J. Fitzmaurice, W. Zeng and D. N.J. Hart
Benzamide Riboside, a Recent Inhibitor of Inosine 5-Monophosphate Dehydrogenase Induces Transferrin Receptors in Cancer Cells
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
759-764
Author(s):
Thomas Szekeres, Jan Sedlak and Ladislav Novotny
Metabolism of the Novel IMP Dehydrogenase Inhibitor Benzamide Riboside
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
781-786
Author(s):
Walter Jager, Alexandra Salamon and Thomas Szekeres
Toxicity and Efficacy of Benzamide Riboside in Cancer Chemotherapy Models
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
787-792
Author(s):
Hiremagalur N. Jayaram, Joel A. Yalowitz, Francisco Arguello, John F. Greene and Jr
Bisphosphonates-Anti-Inflammatory Properties
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
15-28
Author(s):
Walter P. Maksymowych
Trypsin and Chymotrypsin Inhibitors in Insects and Gut Leeches
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
483-491
Author(s):
Liliane Schoofs, Elke Clynen and Michel Salzet
Leech Thrombin Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
493-503
Author(s):
Michel Salzet
Prospects for Anti-Neoplastic Therapies Based on Telomere Biology
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
1-17
Author(s):
sheila A. Stewart and William C. Hahn
Integrins as Novel Drug Targets for Overcoming Innate Drug Resistance
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
37-43
Author(s):
Jason S. Damiano
WT1 as a Novel Target Antigen for Cancer Immunotherapy
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
45-54
Author(s):
Y. Oka, A. Tsuboi, O. A. Elisseeva, K. Udaka and H. Sugiyama